Valeo Pharma Management

Management Kriterienprüfungen 1/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Al Moghaddam

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführerless than a year
Eigentum des Geschäftsführersn/a
Durchschnittliche Amtszeit des Managements2.2yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder1.7yrs

Jüngste Management Updates

Recent updates

Market Might Still Lack Some Conviction On Valeo Pharma Inc. (TSE:VPH) Even After 55% Share Price Boost

Jun 14
Market Might Still Lack Some Conviction On Valeo Pharma Inc. (TSE:VPH) Even After 55% Share Price Boost

Market Cool On Valeo Pharma Inc.'s (TSE:VPH) Revenues Pushing Shares 31% Lower

Apr 20
Market Cool On Valeo Pharma Inc.'s (TSE:VPH) Revenues Pushing Shares 31% Lower

Valeo Pharma Inc. (TSE:VPH) Stocks Pounded By 33% But Not Lagging Industry On Growth Or Pricing

Mar 02
Valeo Pharma Inc. (TSE:VPH) Stocks Pounded By 33% But Not Lagging Industry On Growth Or Pricing

Investors Still Aren't Entirely Convinced By Valeo Pharma Inc.'s (TSE:VPH) Revenues Despite 68% Price Jump

Jan 17
Investors Still Aren't Entirely Convinced By Valeo Pharma Inc.'s (TSE:VPH) Revenues Despite 68% Price Jump

Valeo Pharma Inc. (TSE:VPH) Might Not Be As Mispriced As It Looks After Plunging 29%

Jun 08
Valeo Pharma Inc. (TSE:VPH) Might Not Be As Mispriced As It Looks After Plunging 29%

Analysts Have Just Cut Their Valeo Pharma Inc. (TSE:VPH) Revenue Estimates By 24%

Jun 24
Analysts Have Just Cut Their Valeo Pharma Inc. (TSE:VPH) Revenue Estimates By 24%

Earnings Update: Valeo Pharma Inc. (TSE:VPH) Just Reported And Analysts Are Trimming Their Forecasts

Jun 17
Earnings Update: Valeo Pharma Inc. (TSE:VPH) Just Reported And Analysts Are Trimming Their Forecasts

Have Insiders Been Buying Valeo Pharma Inc. (CSE:VPH) Shares This Year?

Feb 08
Have Insiders Been Buying Valeo Pharma Inc. (CSE:VPH) Shares This Year?

Geschäftsführer

Al Moghaddam (57 yo)

less than a year

Amtszeit

Mr. Al Moghaddam, B. Com. CMA had been a Director at Valeo Pharma Inc. since March 21, 2024 until June 2024 and served as its Chief Development Officer since June 2024 until August 2024 and serves as its C...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Kyle Steiger
Senior VP & Chief Commercial Officer2.2yrsCA$388.21k0.020%
CA$ 872.5
Al Moghaddam
Chief Executive Officerless than a yearkeine Datenkeine Daten
Pascal Tougas
Chief Financial Officerless than a yearkeine Datenkeine Daten
Frederic Dumais
Director of Communications & Investor Relations3.8yrskeine Datenkeine Daten
Guy-Paul Allard
VP of Legal Affairs & Corporate Secretaryno datakeine Daten0.41%
CA$ 18.0k
Jean Fournier
Head of Ophthalmology Business Unit2.2yrskeine Datenkeine Daten

2.2yrs

Durchschnittliche Betriebszugehörigkeit

Erfahrenes Management: VPHDas Führungsteam des Unternehmens gilt als erfahren (2 Jahre durchschnittliche Betriebszugehörigkeit).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Robert Raich
Independent Directorless than a yearkeine Daten0.18%
CA$ 7.9k
Richard MacKay
Chairman of the Advisory Board & Director15.8yrskeine Daten16.44%
CA$ 730.0k
Steven Saviuk
Chairman21.6yrsCA$466.29k0.18%
CA$ 8.1k
Marc Leger
Independent Non-Executive Director2.5yrskeine Daten2.36%
CA$ 104.9k
Richard Lajoie
Independent Directorless than a yearkeine Datenkeine Daten
Charles Bisaillon
Independent Directorless than a yearkeine Datenkeine Daten

1.7yrs

Durchschnittliche Betriebszugehörigkeit

65yo

Durchschnittliches Alter

Erfahrener Vorstand: VPHDie Vorstandsmitglieder gelten nicht als erfahren ( 0.6 Jahre durchschnittliche Amtszeit), was auf einen neuen Vorstand hindeutet.